Vivos Therapeutics, Inc. (VVOS) Technical Analysis
Updated: 2026-05-01 03:16 UTC · Last close: 0.80 (+2.20%) · Resistance: 1.15
Vivos Therapeutics, Inc. (VVOS) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
⬆️ Resistance
1.15
🚀 Bullish Trigger
a clean close above 1.15 would strengthen the upside continuation case.
Quick Read
Process reminder: use the chart for scenario planning, not certainty.
🔺 Technical Setup
RSI(14)
32.6
📊 Technical Summary
Vivos Therapeutics, Inc. (VVOS) closed at 0.80 (+2.20%). Price remains below both the 50-day and 200-day moving averages, which keeps the broader technical backdrop under pressure until stronger recovery signals appear. 20-day momentum is notably weak at -38.45%, with price is trading in the lower part of its roughly 52-week range (0.78–6.95), while ATR14 volatility is elevated at roughly 15.94% of price. RSI(14) is 32.6, reflecting a defensive momentum profile with buyers still struggling to regain control. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD remains below its signal line, which shows that momentum confirmation is still limited. The MACD histogram remains negative, suggesting momentum is still on the softer side. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. Nearby upside pressure sits around 1.15. A decisive move through that level would improve the short-term picture. Latest fundamentals snapshot: Revenue: 6.78M · Net income: -5.40M · EPS (basic): -0.49. The interactive view adds overlays, pattern context and broader chart structure for deeper review.
💼 Fundamentals Snapshot
Source: sec
Company
Vivos Therapeutics, Inc.
CIK (SEC ID)
0001716166
Shares Out.
8.27M
Revenue
6.78M
Net Income
-5.40M
EPS (Basic)
-0.49
Explore more
Note: This is an algorithmic technical snapshot (not financial advice).